Last reviewed: July 17, 2026
Last updated: July 17, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Tirzepatide works by activating two hormone receptors that regulate appetite and blood sugar, making it one of the most studied medications for weight management in recent clinical trials. Getting a tirzepatide prescription for weight loss no longer requires jumping through insurance hoops or waiting months for an appointment. PlexusDx connects qualified patients with licensed prescribers and compounded medications at $289/mo month-to-month, or from $249/mo on the 6-month plan.
Start your GLP-1 program with PlexusDx
One all-inclusive price covers your online provider visit, prescription, compounded medication, and shipping — no membership, no hidden fees. Complete a short intake and a licensed provider takes it from there.
Start your intake →
What Is Tirzepatide and How Does It Support Weight Loss
Tirzepatide is a synthetic peptide that binds to both GLP-1 and GIP receptors in the brain and pancreas. By activating these two pathways simultaneously, tirzepatide slows gastric emptying, increases feelings of fullness, and helps regulate blood sugar levels—all mechanisms that reduce overall calorie intake. Clinical trials showed participants using tirzepatide lost between 15% and 22% of their body weight over 68 weeks, significantly outperforming single-pathway GLP-1 agonists.
Unlike medications that work through a single hormone pathway, tirzepatide's dual-action approach addresses multiple hunger and metabolism systems. This combination allows many patients to achieve meaningful weight reduction while experiencing fewer plateau effects compared to other weight loss medications. The medication is particularly effective for individuals whose genetic profile shows stronger response patterns to GIP or combined GLP-1/GIP activation.
Tirzepatide Prescription Requirements and Medical Eligibility
To obtain a tirzepatide prescription through PlexusDx, patients must qualify based on established medical criteria. Eligibility typically includes a BMI of 30 or higher, or a BMI of 27 or higher with weight-related health conditions such as high blood pressure, type 2 diabetes, or sleep apnea. PlexusDx physicians review each patient's medical history, current medications, and health goals to determine if tirzepatide is appropriate.
A brief telehealth consultation with a PlexusDx-affiliated prescriber takes 20 to 30 minutes and covers your weight loss history, previous medications, lifestyle factors, and any underlying health conditions. The prescriber will discuss potential side effects, expected timeline for results, and dosing plans during this visit. No insurance approval delays or prior authorization requirements apply—qualified patients can receive their first prescription within days of approval.
How PlexusDx Delivers Compounded Tirzepatide Injections
PlexusDx partners exclusively with licensed 503A compounding pharmacies that manufacture tirzepatide injections under strict quality standards. These compounding pharmacies follow FDA regulations and state pharmacy board oversight to ensure purity, potency, and sterility. All medications ship directly to patients' homes with detailed injection instructions, alcohol prep pads, and syringes included in each monthly supply.
Compounded tirzepatide offers the same active pharmaceutical ingredient as brand-name versions but at significantly lower cost. PlexusDx's flat monthly pricing of $289 per month means your dose can increase as your body responds to treatment without price increases. Patients receive their medication within 5 to 7 business days of prescription approval, with ongoing refills handled automatically unless you request changes.
Personalized Tirzepatide Dosing and the Precision Peptide Genetic Test
PlexusDx offers the Precision Peptide Genetic Test as an optional add-on ($298) that identifies how your specific genetic variants influence tirzepatide response. The test analyzes key genetic markers including the GLP1R rs6923761 variant and GIPR rs1800437 variant, both of which influence how effectively your body responds to dual-pathway activation. Understanding your genetic predispositions helps PlexusDx physicians tailor your starting dose and escalation timeline for maximum results.
Standard tirzepatide dosing typically begins at 2.5 mg weekly and increases by 2.5 mg every four weeks until reaching your target maintenance dose. The Precision Peptide Genetic Test provides data on 150+ genetic insights across 14 metabolic pathways and 49 peptides, allowing your prescriber to anticipate your individual response pattern. Patients with specific genetic profiles may benefit from faster dose escalation, modified timelines, or adjusted maintenance doses—personalizing your entire weight loss journey.
Cost, Payment Options, and Getting Started With PlexusDx
PlexusDx tirzepatide injections are $289/mo month-to-month, or from $249/mo on the 6-month plan with a flat-rate pricing model across all commitment tiers. This means whether you're taking 2.5 mg weekly or 15 mg weekly, your monthly cost remains the same—your dose may need to go up, but your price won't. PlexusDx accepts payment from HSA and FSA accounts, making tirzepatide eligible for pre-tax healthcare spending if you have either account type.
Getting started requires scheduling a brief telehealth consultation through the PlexusDx website, completing a health questionnaire, and speaking with a licensed prescriber. No insurance is required, no membership fees apply, and PlexusDx serves all 50 states. Once approved, your first tirzepatide prescription ships within days, with automatic monthly refills continuing until you choose to pause or adjust your treatment plan.
How Your Genetics Relate to GLP-1 Pathways
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection is $289/mo month-to-month, or from $249/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.
Frequently Asked Questions
Is compounded tirzepatide from PlexusDx the same as brand-name Mounjaro?
Compounded tirzepatide contains the identical active pharmaceutical ingredient as brand-name Mounjaro but is manufactured by licensed 503A compounding pharmacies. PlexusDx does not claim compounded medications are FDA-approved; however, they are regulated under state pharmacy board oversight and meet the same quality standards for purity and potency. The clinical effect on weight loss and appetite suppression is equivalent to brand versions at a fraction of the cost.
How much weight can I expect to lose with tirzepatide?
Clinical trials demonstrated average weight loss of 15% to 22% of body weight over 68 weeks when tirzepatide is combined with diet and exercise modifications. Individual results vary based on genetics, adherence to lifestyle changes, and starting weight. PlexusDx patients often report noticeable appetite reduction within the first two weeks and measurable weight loss by weeks 4 to 8 of treatment.
What is the difference between PlexusDx tirzepatide injection and oral options?
PlexusDx offers both compounded tirzepatide injection ($289/mo) and oral tirzepatide ($349/mo). Injections are administered once weekly and generally produce more consistent blood levels and faster weight loss results. Oral versions offer convenience for patients who prefer pills but may have slightly lower bioavailability and longer onset of action.
What side effects should I expect from tirzepatide?
Common side effects include nausea, vomiting, diarrhea, and constipation, most often during the first four weeks of treatment or dose increases. These effects typically decrease as your body adjusts. Serious side effects are rare but may include pancreatitis or thyroid-related issues; PlexusDx prescribers screen for contraindications during your initial consultation and monitor your progress throughout treatment.
How does the Precision Peptide Genetic Test improve my tirzepatide results?
No — the Precision Peptide Genetic Test does not predict your response to tirzepatide or any specific medication. It analyzes pathway-level variants (GIPR) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.
Related Reading
Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
How Long Can You Go Without Taking Mounjaro?
Decoding Mounjaro Dosing: Your Path to Effective Weight Management